loader
Please Wait
Applying Filters...

Looking for Tablet Extended Release Finished Formulations containing TRIACETIN? Find Triacetin based pharmaceutical excipients on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACETAMINOPHEN

02 1ACTOPLUS MET XR

03 1ALBUTEROL SULFATE

04 1ALTOPREV

05 9BUPROPION HYDROCHLORIDE

06 2CIPROFLOXACIN EXTENDED RELEASE

07 1CONCERTA

08 1DEPAKOTE ER

09 3DICLOFENAC SODIUM

10 1DILTIAZEM HYDROCHLORIDE

11 2DIVALPROEX SODIUM

12 1DYANAVEL XR 10

13 1DYANAVEL XR 15

14 1DYANAVEL XR 20

15 1DYANAVEL XR 5

16 2ETODOLAC

17 1EXALGO

18 1FELODIPINE

19 1FORFIVO XL

20 1FORTAMET

21 1GLIPIZIDE

22 1INVEGA

23 1LAMOTRIGINE

24 4LEVETIRACETAM

25 3LITHIUM CARBONATE

26 2METFORMIN HYDROCHLORIDE

27 1METHYLPHENIDATE HYDROCHLORIDE

28 2METOPROLOL SUCCINATE

29 5MINOCYCLINE HYDROCHLORIDE

30 2MORPHINE SULFATE

31 1NEXICLON XR

32 4NIFEDIPINE

33 1OPANA ER

34 1OSMOLEX ER

35 4OXYBUTYNIN CHLORIDE

36 1OXYCONTIN

37 2PALIPERIDONE

38 3PAROXETINE HYDROCHLORIDE

39 1PENTOXIFYLLINE

40 2QUETIAPINE FUMARATE

41 5RANOLAZINE

42 1SOLODYN

43 1VENLAFAXINE HYDROCHLORIDE

44 3VERAPAMIL HYDROCHLORIDE

45 1VOSPIRE ER

46 2ZOLPIDEM TARTRATE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Discovery on Target
Not Confirmed

DIVALPROEX SODIUM

Drug : DEPAKOTE ER

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 21168

Country : US

Patented : No

Abbvie Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

CLONIDINE

Drug : NEXICLON XR

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 22500

Country : US

Patented : Yes

Athena Company Banner

03

arrow
Discovery on Target
Not Confirmed

ETODOLAC

Drug : ETODOLAC

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76174

Country : US

Patented : No

blank

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

ALBUTEROL SULFATE

Drug : VOSPIRE ER

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76130

Country : US

Patented : No

Strides Pharma Science

05

ENDO OPERATIONS
arrow
Discovery on Target
Not Confirmed
ENDO OPERATIONS
Country
arrow
Discovery on Target
Not Confirmed

ZOLPIDEM TARTRATE

Drug : ZOLPIDEM TARTRATE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 78148

Country : US

Patented : No

blank

06

ENDO OPERATIONS
arrow
Discovery on Target
Not Confirmed
ENDO OPERATIONS
Country
arrow
Discovery on Target
Not Confirmed

NIFEDIPINE

Drug : NIFEDIPINE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 77899

Country : US

Patented : No

blank

07

NORVIUM BIOSCIENCE
arrow
Discovery on Target
Not Confirmed
NORVIUM BIOSCIENCE
Country
arrow
Discovery on Target
Not Confirmed

OXYBUTYNIN CHLORIDE

Drug : OXYBUTYNIN CHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76702

Country : US

Patented : No

blank

08

NORVIUM BIOSCIENCE
arrow
Discovery on Target
Not Confirmed
NORVIUM BIOSCIENCE
Country
arrow
Discovery on Target
Not Confirmed

OXYBUTYNIN CHLORIDE

Drug : OXYBUTYNIN CHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76644

Country : US

Patented : No

blank

09

ENDO OPERATIONS
arrow
Discovery on Target
Not Confirmed
ENDO OPERATIONS
Country
arrow
Discovery on Target
Not Confirmed

GLIPIZIDE

Drug : GLIPIZIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76159

Country : US

Patented : No

blank

10

ENDO OPERATIONS
arrow
Discovery on Target
Not Confirmed
ENDO OPERATIONS
Country
arrow
Discovery on Target
Not Confirmed

OXYMORPHONE HYDROCHLORIDE

Drug : OPANA ER

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 21610

Country : US

Patented : Yes

blank